Home › Funds › Tetragon Partners GP Ltd › HRMY

Tetragon Partners GP Ltd position in HRMY

HARMONY BIOSCIENCES HLDGS IN · Health Care

Tetragon Partners GP Ltd reported holding 201,036 shares of HRMY (HARMONY BIOSCIENCES HLDGS IN) in its Q2 2026 13F filing — a position valued at US$7.3M, representing 1.19% of its reported portfolio and ranking #19 among its reported holdings. Tetragon Partners GP Ltd has disclosed HRMY holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

Latest position (Q2 2026)201.04K sh
Reported value held$7.32M
Portfolio Weight1.19%
First reportedQ4 2025
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Tetragon Partners GP Ltd's HRMY position evolved

Tetragon Partners GP Ltd first disclosed a stake in HRMY in Q4 2025 at 82,824 shares (US$3.1M). The position peaked in Q2 2026 at 201,036 shares, worth US$7.3M. Across 3 filings, Tetragon Partners GP Ltd increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 201,036 shares valued at US$7.3M — an increase of 81,696 shares quarter over quarter.. Notable position changes include a 44% increase in Q1 2026 (shares rose 30% over the following quarter), a 68% increase in Q2 2026 (shares rose 8% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 82.82K $3.10M New
Q1 2026 119.34K $3.34M Add
Q2 2026 201.04K $7.32M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About HRMY and 13F data

HRMY (HARMONY BIOSCIENCES HLDGS IN) is a Health Care company. 37 other funds we track also report a position in HRMY — the largest reported positions include ARMISTICE CAPITAL, LLC (US$56.9M), Valor Management LLC (US$29.8M), venBio Partners LLC (US$17.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding HRMY

All HRMY fund holders →

FAQ

How long has Tetragon Partners GP Ltd held HRMY?

Tetragon Partners GP Ltd has disclosed HRMY holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

What is Tetragon Partners GP Ltd's current position in HRMY?

As of Q2 2026, Tetragon Partners GP Ltd holds 201.04K shares of HRMY (HARMONY BIOSCIENCES HLDGS IN), valued at $7.32M, representing 1.19% of its reported portfolio and ranking #19.

Has Tetragon Partners GP Ltd been buying or selling HRMY?

In the latest 13F filing (Q2 2026), Tetragon Partners GP Ltd increased its position in HRMY. The position peaked in Q2 2026 at 201.04K shares.

Which other funds hold HRMY?

Other major institutional holders of HRMY include ARMISTICE CAPITAL, LLC, Valor Management LLC, venBio Partners LLC, among 37 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.